Serum or Plasma Substance Concentration (Bromocresol Green Dye Binding) Test Overview for Patients

The section titled "What This Test Measures" explains in simple terms the substance in your serum or plasma that binds to the bromocresol green dye during the analysis.

Bromocresol green (BCG) is a dye that binds to certain proteins in your blood, particularly albumin. When mixed with your serum or plasma, the dye’s ability to bind is measured, which can reflect overall protein levels or functional integrity. This method is less common today but historically used to assess albumin or other protein-binding capacity.

The part headed "Why It Might Be Ordered" describes the medical reasons a doctor could request this bromocresol green dye binding test for a patient.

Doctors may order this test to investigate conditions affecting protein metabolism, such as liver disease, kidney problems, or nutritional deficiencies. It can also be part of broader evaluations for protein-related disorders, though newer tests are often preferred for specificity.

The section called "Sample Collection and Preparation" tells you how your blood is drawn and processed before the bromocresol green dye binding measurement.

A blood sample is drawn from a vein, typically in the arm. The blood is then separated into serum (liquid after clotting) or plasma (liquid before clotting) for testing. This test requires a fresh sample, as dye binding can change over time.

Under the heading "Clinical Significance", you can read about the meaning of the test outcomes and how they relate to your overall health and protein condition.

While less frequently used today, results from this test can indirectly suggest issues with protein synthesis or breakdown. For example, low binding may indicate liver dysfunction or malnutrition. However, interpretation often requires clinical correlation with other tests or symptoms.